{
    "medicine_id": "53e6fcd484505cf75522024150424405f70a624e",
    "platform_id": "DB04991",
    "metadata": {
        "name": "Potiga 50 mg 1 Tablet film coated",
        "composition": "50 mg 1 XL784",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment in patients with diabetes who have clinically significant proteinuria",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "XL784 is a potent inhibitor of the ADAM 10 metalloprotease MP enzyme a target of significant interest because of its important role in blood vessel formation and cell proliferation XL784 was specifically optimized to spare matrix metalloprotease 1 MMP1 thus potentially significantly enhancing its safety profile and enabling higher dosing in comparison to other MMP inhibitors Data from a Phase 1 clinical trial of orally administered XL784 in 70 healthy volunteers showed single doses of the compound to be free of side effects and to have an attractive pharmacokinetic profile XL784 has been reformulated for chronic administration and has demonstrated dose proportional absorption was orally bioavailable and was well tolerated",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}